Eli Lilly and Company
LLYHealthcare Drug Manufacturers General
Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +16.3%
- Free cash flow
- +21.8%
- Total debt
- +15.0%
Quarter to September 2026, against a year earlier
Follow LLY
Alert me
Ratios over time FY16 to FY25
Returns on capital
ROIC was 27.3% in FY25, the highest of these ten years. ROE, at 101.2%, is far above it because equity is small against the capital the business uses.
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 19.1% | −1.6% | 28.6% | 122.3% | 145.3% | 74.5% | 62.7% | 48.4% | 84.3% | 101.2% |
| ROIC | 11.1% | 7.2% | 16.0% | 19.8% | 20.2% | 19.3% | 19.1% | 15.4% | 20.4% | 27.3% |
Debt
Net debt is 1.19× a year’s EBITDA. Debt is 1.54× equity, against 5.72× in FY19.
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / equity | 0.7× | 1.2× | 0.9× | 5.7× | 2.8× | 1.7× | 1.4× | 1.7× | 2.0× | 1.5× |
| Net debt / EBITDA | 0.9× | 1.6× | 0.6× | 2.1× | 1.7× | 1.4× | 1.4× | 1.9× | 1.7× | 1.2× |
Cash cycle, in days
Customers pay in 113 days, inventory is held 454 days and suppliers are paid in 178. Cash is tied up for 389 days between paying for goods and being paid.
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash cycle | 223 | 346 | 246 | 229 | 261 | 215 | 240 | 285 | 297 | 389 |
| Days to pay suppliers | 86 | 116 | 94 | 109 | 107 | 83 | 106 | 134 | 140 | 178 |
| Days to be paid | 82 | 96 | 98 | 91 | 103 | 105 | 109 | 121 | 108 | 113 |
Per share, from FY16
Since FY16, per share: free cash flow has grown 11.8% a year; revenue has grown 15.4% a year; book value has grown 9.28% a year.
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | 1.0× | 1.2× | 1.1× | 1.1× | 1.5× | 1.8× | 1.7× | 0.2× | 1.1× | 2.7× |
| Revenue | 1.0× | 0.9× | 1.0× | 1.2× | 1.3× | 1.6× | 1.6× | 1.9× | 2.5× | 3.6× |
| Book value | 1.0× | 0.8× | 0.8× | 0.2× | 0.5× | 0.8× | 0.9× | 0.9× | 1.2× | 2.2× |
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
46.83 | 65.93 | 102.10 | 52.90 | 44.99 | 24.83 | 14.97 | 36.97 | 0.00 | 28.91 |
Piotroski F-Score |
7 | 6 | 5 | 7 | 6 | 6 | 6 | 9 | 4 | 6 |
Altman Z-Score |
8.61 | 7.89 | 6.99 | 6.47 | 5.14 | 3.57 | 3.23 | 3.52 | 2.75 | 3.42 |
P/S ratio |
14.79 | 15.44 | 15.62 | 11.53 | 8.85 | 6.24 | 5.48 | 5.53 | 4.46 | 3.72 |
P/FCF ratio |
86.31 | 116.64 | 216.52 | 56.77 | 38.74 | 27.75 | 29.05 | 25.18 | 18.00 | 18.37 |
Altman Z″-Score (non-manufacturers) |
3.79 | 2.26 | 1.26 | 2.04 | 2.17 | 2.27 | 1.66 | 3.03 | 2.35 | 3.21 |
Beneish M-Score |
(1.91) | (2.21) | (2.18) | (2.58) | (2.47) | (2.26) | (2.52) | (2.64) | (3.04) | (2.62) |
P/Operating CF |
299.01 | 281.04 | (1,708.65) | 197.95 | 110.77 | 84.42 | 62.32 | 82.09 | 51.10 | 39.35 |
P/B ratio |
36.34 | 48.72 | 49.07 | 30.54 | 27.37 | 26.31 | 45.34 | 10.90 | 7.64 | 5.61 |
Price to Tangible BV |
68.31 | 297.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.03 | 27.25 | 13.73 |
EV/Sales |
15.34 | 16.02 | 16.14 | 12.02 | 9.30 | 6.77 | 6.07 | 5.62 | 4.56 | 3.83 |
EV/EBITDA |
35.32 | 49.20 | 68.98 | 39.67 | 33.33 | 22.51 | 21.81 | 23.47 | 25.49 | 17.09 |
EV/Operating CF |
59.45 | 81.84 | 129.89 | 45.24 | 35.77 | 25.56 | 27.99 | 21.85 | 16.21 | 16.76 |
EV/FCF |
89.46 | 121.06 | 223.69 | 59.19 | 40.75 | 30.09 | 32.13 | 25.56 | 18.39 | 18.92 |
Quick Ratio |
0.78 | 0.58 | 0.52 | 0.63 | 0.80 | 0.85 | 0.68 | 1.11 | 0.91 | 0.98 |
Current Ratio |
1.58 | 1.15 | 0.94 | 1.05 | 1.23 | 1.40 | 1.16 | 1.73 | 1.32 | 1.37 |
Net Debt/EBITDA |
1.19 | 1.72 | 1.93 | 1.45 | 1.45 | 1.75 | 2.09 | 0.56 | 1.57 | 0.90 |
Debt/Assets |
36.33% | 36.24% | 28.62% | 29.78% | 31.44% | 35.59% | 39.30% | 23.45% | 30.34% | 26.55% |
Debt/Equity |
1.54 | 2.00 | 1.69 | 1.37 | 1.68 | 2.85 | 5.72 | 0.94 | 1.17 | 0.73 |
Asset Turnover |
0.68 | 0.63 | 0.60 | 0.58 | 0.59 | 0.57 | 0.54 | 0.48 | 0.48 | 0.57 |
Operating CF/Net income |
0.81 | 0.83 | 0.81 | 1.21 | 1.32 | 1.05 | 0.58 | 1.71 | (27.51) | 1.77 |
Capex/Depreciation |
(3.93) | (2.86) | (2.26) | (1.22) | (0.85) | (1.05) | (0.84) | (0.75) | (0.69) | (0.64) |
| 101.16% | 84.26% | 48.43% | 62.67% | 74.52% | 145.32% | 122.26% | 28.63% | (1.59%) | 19.10% | |
| 21.59% | 14.84% | 9.23% | 12.71% | 11.70% | 14.42% | 20.00% | 7.27% | (0.49%) | 7.36% | |
ROIC |
27.34% | 20.39% | 15.37% | 19.12% | 19.29% | 20.20% | 19.80% | 16.01% | 7.25% | 11.11% |
Return on Tangible Assets |
45.79% | 49.33% | 46.18% | 56.56% | 45.07% | 45.33% | 84.82% | 19.40% | (1.51%) | 22.14% |
Average Days of Receivables |
112.87 | 107.58 | 121.26 | 109.46 | 104.75 | 103.06 | 90.62 | 98.10 | 96.16 | 81.98 |
Research and Development Expense of Revenue |
20.46% | 24.40% | 27.29% | 25.19% | 24.47% | 24.35% | 25.07% | 23.50% | 25.51% | 25.02% |
Selling, General and Administrative Expense of Revenue |
17.02% | 19.08% | 21.70% | 22.57% | 22.71% | 24.94% | 27.84% | 27.80% | 29.95% | 30.76% |
Intangible Assets out of Total Assets |
0.11 | 0.15 | 0.19 | 0.23 | 0.24 | 0.24 | 0.26 | 0.06 | 0.19 | 0.21 |
Share Based Compensation of Revenue |
0.96% | 1.43% | 1.84% | 1.30% | 1.21% | 1.26% | 1.40% | 1.30% | 1.41% | 1.20% |
Graham Net Nets |
(0.03) | (0.05) | (0.05) | (0.06) | (0.08) | (0.15) | (0.19) | (0.10) | (0.16) | (0.12) |
Graham Number |
123.57 | 64.62 | 39.68 | 43.07 | 37.34 | 31.34 | 23.93 | 27.34 | 0.00 | 27.79 |
Earnings Yield |
2.14% | 1.52% | 0.98% | 1.89% | 2.22% | 4.03% | 6.68% | 2.70% | (0.24%) | 3.46% |
Free Cash Flow Yield |
1.16% | 0.86% | 0.46% | 1.76% | 2.58% | 3.60% | 3.44% | 3.97% | 5.56% | 5.44% |
Revenue per Share |
72.64 | 50.01 | 37.91 | 31.65 | 31.22 | 27.04 | 23.97 | 20.91 | 18.99 | 20.05 |
Operating CF per Share |
18.74 | 9.79 | 4.71 | 8.41 | 8.12 | 7.16 | 5.19 | 5.38 | 5.34 | 4.58 |
Capex per Share |
(8.74) | (5.62) | (3.83) | (2.06) | (1.44) | (1.53) | (1.11) | (1.18) | (1.02) | (0.91) |
Free Cash Flow per Share |
10.00 | 4.18 | 0.88 | 6.36 | 6.68 | 5.63 | 4.08 | 4.20 | 4.31 | 3.67 |
Cash per Share |
8.10 | 3.63 | 3.25 | 2.45 | 4.31 | 4.06 | 2.62 | 7.21 | 7.64 | 5.71 |
Shareholders Equity per Share |
29.57 | 15.85 | 12.07 | 11.95 | 10.09 | 6.42 | 2.90 | 10.61 | 11.09 | 13.30 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
29.57 | 15.85 | 12.07 | 11.95 | 10.09 | 6.42 | 2.90 | 10.61 | 11.09 | 13.30 |
Free Cash Flow |
8,972.00 | 3,760.00 | 792.00 | 5,731.40 | 6,056.10 | 5,111.70 | 3,802.70 | 4,313.90 | 4,538.80 | 3,887.40 |
Working Capital |
20,401.00 | 4,364.00 | (1,566.20) | 896.30 | 3,399.70 | 4,980.50 | 1,934.40 | 8,661.50 | 4,666.20 | 4,114.80 |
Capital Expenditures |
(7,841.00) | (5,058.00) | (3,448.00) | (1,854.30) | (1,309.80) | (1,387.90) | (1,033.90) | (1,210.60) | (1,076.80) | (963.60) |
Net Current Asset Value |
(30,312.00) | (31,703.00) | (27,415.60) | (20,679.90) | (21,198.80) | (23,345.80) | (22,877.40) | (12,449.70) | (14,111.00) | (9,624.00) |
EV/EBIT |
38.00 | 55.95 | 85.29 | 48.15 | 41.45 | 27.43 | 27.21 | 34.16 | 45.43 | 24.93 |
Capex to Sales |
0.12 | 0.11 | 0.10 | 0.07 | 0.05 | 0.06 | 0.05 | 0.06 | 0.05 | 0.05 |
Price to Operating Income |
36.66 | 53.90 | 82.56 | 46.18 | 39.41 | 25.30 | 24.60 | 33.65 | 44.47 | 24.21 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | 0.10 | 0.12 | 0.15 | 0.17 | 0.15 | 0.16 | 0.20 | 0.18 | 0.18 |
Cash ROIC |
12.02% | 8.16% | 2.47% | 20.67% | 21.32% | 19.58% | 18.48% | 15.07% | 13.61% | 12.78% |
Accounts Receivable Turnover |
3.90 | 3.66 | 3.43 | 3.42 | 3.76 | 3.94 | 3.94 | 3.89 | 3.98 | 4.80 |
Accounts Payable Turnover |
2.57 | 2.89 | 3.13 | 3.68 | 4.46 | 3.64 | 3.61 | 3.58 | 3.22 | 4.25 |
Inventory Turnover |
1.04 | 1.26 | 1.40 | 1.62 | 1.86 | 1.53 | 1.50 | 1.24 | 1.11 | 1.63 |
Average Days of Payables |
177.65 | 140.01 | 133.94 | 106.29 | 83.38 | 106.95 | 108.64 | 94.11 | 115.77 | 86.25 |
Days of Inventory on Hand |
453.91 | 329.06 | 297.53 | 237.27 | 193.96 | 264.95 | 246.68 | 241.54 | 365.87 | 227.68 |
Average Receivables |
16,715.50 | 12,306.10 | 9,947.55 | 8,343.05 | 7,528.10 | 6,235.25 | 5,659.15 | 5,519.50 | 5,014.25 | 4,418.95 |
Average Payables |
4,304.00 | 2,913.90 | 2,264.70 | 1,800.60 | 1,638.65 | 1,506.00 | 1,306.20 | 1,308.90 | 1,380.00 | 1,343.75 |
Average Inventory |
10,666.50 | 6,680.90 | 5,041.25 | 4,097.85 | 3,933.15 | 3,585.50 | 3,144.40 | 3,778.20 | 4,010.10 | 3,503.85 |
Average Assets |
95,595.50 | 71,360.65 | 56,748.05 | 49,147.90 | 47,719.55 | 42,959.60 | 41,597.25 | 44,444.70 | 41,893.45 | 37,187.40 |
Average Common Equity |
20,403.50 | 12,567.85 | 10,819.55 | 9,965.10 | 7,490.00 | 4,262.15 | 6,804.10 | 11,288.50 | 12,874.20 | 14,335.40 |